Navid Manuchehrabadi MSc, PhD

Navid received a B.S. degree in Biomedical/Electrical Engineering and M.S. in Biomedical and Mechanical Engineering from Leibniz University, Germany in 2009, later he completed his Ph.D. degree in Mechanical Engineering from UMBC, Baltimore, in 2014. As a scientist trained in the fundamentals of Biomedical Engineering and Mechanical Engineering, his research interfaces the disciplines of organ banking and regenerative medicine, tissue engineering, biomedical devices, cancer detection and treatment modalities, bioheat transfer, thermal fluid sciences, Transport phenomena in biological systems, and Bio-nanotechnology.

Navid completed 3yrs as a Post-Doctoral Research Fellow at the University of Minnesota. In this role, he focused on clinical development and application of irreversible electroporation ablation for cancer patient therapy, with a focus on therapy characterization, as well as clinical treatment planning, implementation, and evaluation. In addition, he applied a new technology “Nanowarming” for the first time to successfully rewarm cryopreserved organs in large volumes (Manuchehrabadi et al., STM 2017).

Prior to UofM, his graduate studies were completed at the University of Maryland, with an emphasis on nanoparticle application in cancer therapy, his research was focused on studying the nanoparticles mediated LASER photothermal therapy. The integration of experimental and computational approaches was critical to identifying the underlying mechanisms of nanoparticle interaction with LASER. The research is of clinical significance, since it provides guidance to clinicians for planning laser photothermal therapy in the most efficient and least invasive manner, thereby maximizing damage to the cancerous cells while conserving the healthy prostatic tissue, including the sensitive neurovascular bundle.

Navid has since taken his experiences and incorporated them into R&D programs for the generation and development of pulsed electric field (PEF) therapies, first as a Principal Engineer at Angiodynamics. In this role, Navid led a cross-functional team of experts to develop the application of PEFs for new clinical objectives using advanced approaches and technology, with a clinically-minded focus on translational development to generate meaningful, real-world improvements in patient outcomes. Navid has 4 US and International Patents pending, 20 peer-reviewed articles with over 700 citations, 2 book chapters, and 21 US and International conference proceedings.